Commander, Marine Corps System Command, Code CTQ, 2033 Barnett Avenue, Ste 315, Quantico, VA 22134-5010

A -- BASIC AND APPLIED RESERACH IN NON-LETHAL WEAPONS SOL M67854-00-R-3048 DUE 053100 POC Peggy Smith, Contract Specialist, (703) 784-5822 x252 E-MAIL: Click here to contact the Contract Specialist via, SmithPL@mcsc.usmc.mil. Synopsis: (1) General Statement of Research Need Marine Corps Systems Command (MCSC), in support of the Joint Non-Lethal Weapons Directorate (JNLWD), is soliciting initial proposals and final proposals which address basic research and development for the application and employment of new nonkinetic/limited effects/non-lethal weapons for personnel incapacitation. (Note: Incapacitation is defined as "To produce temporary and reversible physiological or psychological effects that will render an individual(s) incapable of concerted effort in performing routine tasks." For example, an individual who has been incapacitated should not be capable of shooting a gun or physically attacking another individual.) Submissions may include studies and analysis or the assimilation of new and/or existing technologies. The requirement is for studies to be conducted over a period not longer than two years. It is anticipated that three to five projects will be funded, with awards in the range of $300-500 K. All proposals selected for funding will be required to submit quarterly status reports that include financial data and give a Director's review biannually. At the project completion a comprehensive report and outbrief will be required. An evaluation team will recommend at the conclusion of each project whether to further pursue this technology. (2) Instructions for Preparation of Initial Proposal and Proposals Offerors are invited to submit four (4) copies, one of which shall be in MSWord 97 format, of an initial proposal. The initial proposal should not exceed five (5) pages of text and should: (a) describe the proposed concept; (b) provide background information in areas of technical, historical and applicability; (c) detail the work to be performed; (d) discuss associated risks; (e) describe deliverables; and (f) estimate costs for the areas of personnel incapacitation technology and health effects as detailed below: 1. Personnel incapacitation technology- The proposal shall identify the incapacitation technology, explain how and why it would be effective, and provide rational for verifying the desired effect. Specific areas to address include: a. What type of technology is involved? Chemical (inhalation, skin contact, etc)? Electronic? Electromagnetic? Mechanical? b. What is the proposed delivery mechanism? c. What indicates that the technology will successfully incapacitate an individual? (Specific research, analogy to other systems, currently fielded capability, theoretical evaluation). d. What is the proposed operational concept for this technology? (Does the technology target crowds or individuals, is it employed in enclosed spaces, etc.) e. What areas or gaps in the technology need to be researched/explored? 2. Health Effects -- The proposal should identify specific research that will allow a thorough characterization. The proposal should be able to identify the effect the weapon will have on the targeted individual(s), and address the overall health effects associated with employment of the system. Counter-personnel non-lethal systems should have reversible effects (permanent/severe injuries should be minimized). The desire is for the weapon effects to become inert and/or have no residual effect on humans with the simple passage of time. However, no funding during this phase will be allowed for actual human or animal testing. : a. What is the mechanism for the desired effect? b. What are the important parameters for describing the desired effect and what is the threshold for effectiveness in terms of those parameters? c. What is the duration of the desired effect? d. What are the most likely undesired health effects from the use of the technology? e. What are the important parameters for describing the undesired health effects and what are the thresholds for those undesired effects? f. What is the variability in response over the range of the human population? Offerors submitting the most promising initial proposal will be invited to submit a full technical and cost proposal on all or part of their initial proposal submission. However, any such invitation does not assure a subsequent award. Any offeror may submit a final proposal even if its initial proposal was not identified as promising or if no initial proposal is submitted; however any final proposal submission would be made without the benefit of feedback prior to final proposal submission. The initial deadline for initial proposals will be 1600 EST 31 May 2000. Final proposals will be required by 1600 EST, 31 July 2000. Offerors must state in their initial proposal and final proposal that it is submitted in response to this BAA. This BAA provides no funding for initial proposal or subsequent proposal development purposes. All initial proposals will be acknowledged. Initial proposals will not be returned after evaluation. (3) Criteria for Selecting Proposals, Their Relative Importance, and the Method of Evaluation The selection of proposals for award will be based on a scientific review of proposals submitted in response to each BAA. In accordance withFAR 35.016(e), initial proposals and full proposals will be evaluated using the following criteria, shown in order of importance: (1) Technical Merit. (degree to which new and creative solutions to technical issues important to MCSC are proposed; offeror's ability to implement the proposed approach as demonstrated by specific accomplishments in the technical field to be studied.) (2) Importance to Agency Program. (3) Availability of funds. (4) Cost realism and reasonableness. (5) Past Performance. (For example: Ability to comply with performance schedules, prior experience, quality, management) "THE GOVERNMENT RESERVES THE RIGHT TO SELECT FOR AWARD ANY, ALL, PART, OR NONE OF THE RESPONSES RECEIVED." This CBD notice itself constitutes the BAA as contemplated by FAR 6.102(d)(2). Awards may take the form of a cooperative agreement, grant, or other agreement. Unless otherwise stated herein, additional written information is not available. No formal RFP or other solicitation regarding this announcement will be issued. Requests for the same will be disregarded. Initial proposal and proposals should be submitted by the due dates cited in the BAA to the responsible POC at Marine Corps Systems Command, 3041A McCawley Avenue, Code CTQ3 PLS, Quantico, VA 22134. The listed POC should be used for express mail purposes. Questions regarding contractual matters relating to this BAA should be directed to Ms. Peggy Smith, Marine Corps Systems Command, 2033 Barnett Avenue, Suite 315, Code CTQ3 PLS, Quantico, VA 22134/ (703) 784-5822 x252; (703) 784-5826 (FAX); email: smithpl@mcsc.usmc.mil Questions regarding technical matters should be directed to Dr. Ken Tiedge, Joint Non-Lethal Weapons Directorate, 3097 Range Road, Quantico, VA 22134 (703) 784-2997 x232; (703) 784-3178 (FAX); email: tiedgekw@hqmc.usmc.mil Posted 04/19/00 (W-SN446630). (0110)

Loren Data Corp. http://www.ld.com (SYN# 0002 20000421\A-0002.SOL)